Buy Suven Life Sciences, price target Rs 326: Kunal Bothra

Kunal Bothra of Independent Analyst has a buy call on Suven Life Sciences Ltd. with a target price of Rs 326.0 . The current price of Suven Life Sciences Ltd. is Rs 312.9 . Kunal Bothra recommended to keep a stoploss at Rs 305 .

Suven Life Sciences Ltd., incorporated in the year 1989, is a Mid Cap company (having a market cap of Rs 4006.85 Crore) operating in Pharmaceuticals sector.

Suven Life Sciences Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates) which contributed Rs 595.47 Crore to Sales Value (89.74 % of Total Sales), Sale of services which contributed Rs 49.88 Crore to Sales Value (7.51 % of Total Sales), Export Incentives which contributed Rs 16.92 Crore to Sales Value (2.55 % of Total Sales) and Duty Drawback which contributed Rs 1.23 Crore to Sales Value (0.18 % of Total Sales)for the year ending 31-Mar-2019.


For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 274.31 Crore, up 37.86 % from last quarter Sales of Rs 198.99 Crore and up 206.42 % from last year same quarter Sales of Rs 89.52 Crore Company has reported net profit after tax of Rs 63.31 Crore in latest quarter.

The company’s top management includes Dr.M R Naidu, Mr.D G Prasad, Mr.M Gopalakrishna, Mr.Santanu Mukherjee, Mr.Venkateswarlu Jasti, Mrs.J A S Padmaja, Mrs.Sudharani Jasti, Prof.Seyed E Hasnain. Company has Tukaram & Co. LLP as its auditoRs As on 30-06-2019, the company has a total of 127,282,478 shares outstanding.